Outsourced Clinical Trials & Formulation Market

Market Study on Outsourced Clinical Trials & Formulations: Oral Dosage Form to Drive Substantial Market Growth Going Forward

Outsourced Clinical Trials & Formulation Market Segmented By Oral dosage Forms, Injectable Dosage Forms Product in API Manufacturing, Fill-Finish Product Manufacturing, Drug Product Development, Packaging / labeling

  • March-2022
  • PMRREP33016
  • 213 Pages
  • Healthcare
  • PPT, PDF, WORD, EXCEL

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Product Innovation/ Development Trends

4. Key Success factors

    4.1. Key Strategies Adopted by market players

    4.2. Porters Analysis

    4.3. PESTLE Analysis

    4.4. Key Regulations

    4.5. Value Chain Analysis

5. Market Background

    5.1. Macro-Economic Factors

        5.1.1. Global GDP Growth Outlook

        5.1.2. Global Healthcare Outlook

    5.2. Forecast Factors - Relevance & Impact

        5.2.1. Rising Geriatric Population

        5.2.2. Rising incidence of Chronic Diseases

        5.2.3. Patent Expiry and Increasing Demand For Generic Drugs

    5.3. Market Dynamics

        5.3.1. Drivers

        5.3.2. Restraints

        5.3.3. Opportunity Analysis

6. COVID19 Crisis Analysis

    6.1. Current Perspectives on Coronavirus Outbreak

    6.2. Current Economic Outlook & Recovery Scenario

    6.3. COVID19 and Impact Analysis

        6.3.1. Revenue By Product

        6.3.2. Revenue By End User

        6.3.3. Revenue By Region

7. Global Outsourced Clinical Trials & Formulation Market Demand (in Value or Size in US$ Mn) Analysis 2016-2021 and Forecast 2022-2027, by Product

    7.1. Historical Market Value (US$ Mn) Analysis, 2016–2021

    7.2. Current and Future Market Value (US$ Mn) Projections, 2022–2027

        7.2.1. Y-o-Y Growth Trend Analysis

        7.2.2. Absolute $ Opportunity Analysis

8. Global Outsourced Clinical Trials & Formulation Market Analysis 2016-2021 and Forecast 2022-2027, by Product

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (US$ Mn) Analysis By Product, 2016-2021

    8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product, 2022-2027

        8.3.1. Oral Dosage Products

            8.3.1.1. Solid dosage Product

            8.3.1.2. Liquid Dosage Product

            8.3.1.3. Semi-solid Dosage Product

        8.3.2. Injectable Dosage Product

        8.3.3. Others

    8.4. Market Attractiveness Analysis By Product

9. Global Outsourced Clinical Trials & Formulation Market Analysis 2016-2021 and Forecast 2022-2027, by Application

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Mn) Analysis By Application, 2016-2021

    9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2022-2027

        9.3.1. API Manufacturing

        9.3.2. Fill Finish Product Manufacturing

        9.3.3. Drug Product Development

        9.3.4. Packaging / Labelling

        9.3.5. Others

    9.4. Market Attractiveness Analysis By Application

10. Global Outsourced Clinical Trials & Formulation Market Analysis 2016-2021 and Forecast 2022-2027, by End User

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) Analysis By End User, 2016-2021

    10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2022 - 2027

        10.3.1. Big Pharmaceutical and Biotech Companies

        10.3.2. Small and Medium Size Pharma/Biotech Companies

        10.3.3. Emerging/Virtual Pharma Companies

        10.3.4. Nutraceutical Companies

    10.4. Market Attractiveness Analysis By End User

11. Global Outsourced Clinical Trials & Formulation Market Analysis 2016-2021 and Forecast 2022-2027, by Region

    11.1. Introduction

    11.2. Historical Market Size (US$ Mn) Analysis By Region, 2016-2021

    11.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2022 - 2027

        11.3.1. North America

        11.3.2. Europe

        11.3.3. Asia pacific

        11.3.4. Rest of the World

    11.4. Market Attractiveness Analysis By Region

12. North America Outsourced Clinical Trials & Formulation Market Analysis 2016-2021 and Forecast 2022-2027

    12.1. Introduction

    12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021

    12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2027

        12.3.1. By Country

            12.3.1.1. U.S.

            12.3.1.2. Canada

        12.3.2. By Product

        12.3.3. By Application

        12.3.4. By End User

    12.4. Market Attractiveness Analysis

    12.5. Drivers and Restraints - Impact Analysis

13. Europe Outsourced Clinical Trials & Formulation Market Analysis 2016-2021 and Forecast 2022-2027

    13.1. Introduction

    13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021

    13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2027

        13.3.1. By Country

            13.3.1.1. U.K.

            13.3.1.2. Germany

            13.3.1.3. France

            13.3.1.4. Italy

            13.3.1.5. Spain

            13.3.1.6. BENELUX

            13.3.1.7. Russia

            13.3.1.8. BENELUX

            13.3.1.9. Rest of Europe

        13.3.2. By Product

        13.3.3. By Application

        13.3.4. By End User

    13.4. Market Attractiveness Analysis

    13.5. Drivers and Restraints - Impact Analysis

14. Asia Pacific Outsourced Clinical Trials & Formulation Market Analysis 2016-2021 and Forecast 2022-2027

    14.1. Introduction

    14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021

    14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2027

        14.3.1. By Country

            14.3.1.1. China

            14.3.1.2. Japan

            14.3.1.3. South Korea

            14.3.1.4. India

            14.3.1.5. Australia and New Zealand

            14.3.1.6. ASEAN

            14.3.1.7. Rest of Asia Pacific

        14.3.2. By Product

        14.3.3. By Application

        14.3.4. By End User

    14.4. Market Attractiveness Analysis

    14.5. Drivers and Restraints - Impact Analysis

15. Rest of the World Outsourced Clinical Trials & Formulation Market Analysis 2016-2021 and Forecast 2022-2027

    15.1. Introduction

    15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021

    15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2027

        15.3.1. By Product

        15.3.2. By Application

        15.3.3. By End User

    15.4. Market Attractiveness Analysis

    15.5. Drivers and Restraints - Impact Analysis

16. Market Structure Analysis

    16.1. Market Analysis y Tier of Companies

    16.2. Market Share Analysis of Top Players

17. Competition Analysis

    17.1. Competition Dashboard

    17.2. Competition Benchmarking

    17.3. Competition Deep Dive (Tentative List)

        17.3.1. Lonza Group

            17.3.1.1. Overview

            17.3.1.2. Product Portfolio

            17.3.1.3. Key Financials

            17.3.1.4. SWOT Analysis

            17.3.1.5. Sales Footprint

            17.3.1.6. Strategy Overview

        17.3.2. Catalent, Inc.

            17.3.2.1. Overview

            17.3.2.2. Product Portfolio

            17.3.2.3. Key Financials

            17.3.2.4. SWOT Analysis

            17.3.2.5. Sales Footprint

            17.3.2.6. Strategy Overview

        17.3.3. Thermo Fisher Scientific Inc. (Patheon)

            17.3.3.1. Overview

            17.3.3.2. Product Portfolio

            17.3.3.3. Key Financials

            17.3.3.4. SWOT Analysis

            17.3.3.5. Sales Footprint

            17.3.3.6. Strategy Overview

        17.3.4. Piramal Pharma Solutions

            17.3.4.1. Overview

            17.3.4.2. Product Portfolio

            17.3.4.3. Key Financials

            17.3.4.4. SWOT Analysis

            17.3.4.5. Sales Footprint

            17.3.4.6. Strategy Overview

        17.3.5. BioXcellence (Boehringer Ingelheim International GmbH)

            17.3.5.1. Overview

            17.3.5.2. Product Portfolio

            17.3.5.3. Key Financials

            17.3.5.4. SWOT Analysis

            17.3.5.5. Sales Footprint

            17.3.5.6. Strategy Overview

        17.3.6. Siegfried Holding AG

            17.3.6.1. Overview

            17.3.6.2. Product Portfolio

            17.3.6.3. Key Financials

            17.3.6.4. SWOT Analysis

            17.3.6.5. Sales Footprint

            17.3.6.6. Strategy Overview

        17.3.7. Evotec A.G.

            17.3.7.1. Overview

            17.3.7.2. Product Portfolio

            17.3.7.3. Key Financials

            17.3.7.4. SWOT Analysis

            17.3.7.5. Sales Footprint

            17.3.7.6. Strategy Overview

        17.3.8. Ascendia Pharmaceuticals

            17.3.8.1. Overview

            17.3.8.2. Product Portfolio

            17.3.8.3. Key Financials

            17.3.8.4. SWOT Analysis

            17.3.8.5. Sales Footprint

            17.3.8.6. Strategy Overview

        17.3.9. Experic Services

            17.3.9.1. Overview

            17.3.9.2. Product Portfolio

            17.3.9.3. Key Financials

            17.3.9.4. SWOT Analysis

            17.3.9.5. Sales Footprint

            17.3.9.6. Strategy Overview

        17.3.10. Quotient Sciences

            17.3.10.1. Overview

            17.3.10.2. Product Portfolio

            17.3.10.3. Key Financials

            17.3.10.4. SWOT Analysis

            17.3.10.5. Sales Footprint

            17.3.10.6. Strategy Overview

        17.3.11. Velesco Pharmaceutical Services, Inc.

            17.3.11.1. Overview

            17.3.11.2. Product Portfolio

            17.3.11.3. Key Financials

            17.3.11.4. SWOT Analysis

            17.3.11.5. Sales Footprint

            17.3.11.6. Strategy Overview

        17.3.12. Elements Group (Avomeen)

            17.3.12.1. Overview

            17.3.12.2. Product Portfolio

            17.3.12.3. Key Financials

            17.3.12.4. SWOT Analysis

            17.3.12.5. Sales Footprint

            17.3.12.6. Strategy Overview

        17.3.13. VxP Pharma

            17.3.13.1. Overview

            17.3.13.2. Product Portfolio

            17.3.13.3. Key Financials

            17.3.13.4. SWOT Analysis

            17.3.13.5. Sales Footprint

            17.3.13.6. Strategy Overview

        17.3.14. Adare Pharmaceuticals, Inc.

            17.3.14.1. Overview

            17.3.14.2. Product Portfolio

            17.3.14.3. Key Financials

            17.3.14.4. SWOT Analysis

            17.3.14.5. Sales Footprint

            17.3.14.6. Strategy Overview

        17.3.15. KP Pharmaceutical Technology Inc.

            17.3.15.1. Overview

            17.3.15.2. Product Portfolio

            17.3.15.3. Key Financials

            17.3.15.4. SWOT Analysis

            17.3.15.5. Sales Footprint

            17.3.15.6. Strategy Overview

        17.3.16. Enteris Biopharma, Inc.

            17.3.16.1. Overview

            17.3.16.2. Product Portfolio

            17.3.16.3. Key Financials

            17.3.16.4. SWOT Analysis

            17.3.16.5. Sales Footprint

            17.3.16.6. Strategy Overview

        17.3.17. Aenova Holding GmbH

            17.3.17.1. Overview

            17.3.17.2. Product Portfolio

            17.3.17.3. Key Financials

            17.3.17.4. SWOT Analysis

            17.3.17.5. Sales Footprint

            17.3.17.6. Strategy Overview

        17.3.18. Ardena Holding NV

            17.3.18.1. Overview

            17.3.18.2. Product Portfolio

            17.3.18.3. Key Financials

            17.3.18.4. SWOT Analysis

            17.3.18.5. Sales Footprint

            17.3.18.6. Strategy Overview

        17.3.19. Pharmaceutics International, Inc.

            17.3.19.1. Overview

            17.3.19.2. Product Portfolio

            17.3.19.3. Key Financials

            17.3.19.4. SWOT Analysis

            17.3.19.5. Sales Footprint

            17.3.19.6. Strategy Overview

        17.3.20. Alcami Corporation, Inc.

            17.3.20.1. Overview

            17.3.20.2. Product Portfolio

            17.3.20.3. Key Financials

            17.3.20.4. SWOT Analysis

            17.3.20.5. Sales Footprint

            17.3.20.6. Strategy Overview

        17.3.21. NextPharma Technologies

            17.3.21.1. Overview

            17.3.21.2. Product Portfolio

            17.3.21.3. Key Financials

            17.3.21.4. SWOT Analysis

            17.3.21.5. Sales Footprint

            17.3.21.6. Strategy Overview

        17.3.22. Corden Pharma International GmbH

            17.3.22.1. Overview

            17.3.22.2. Product Portfolio

            17.3.22.3. Key Financials

            17.3.22.4. SWOT Analysis

            17.3.22.5. Sales Footprint

            17.3.22.6. Strategy Overview

        17.3.23. Corerx, Inc.

            17.3.23.1. Overview

            17.3.23.2. Product Portfolio

            17.3.23.3. Key Financials

            17.3.23.4. SWOT Analysis

            17.3.23.5. Sales Footprint

            17.3.23.6. Strategy Overview

        17.3.24. Recipharm AB

            17.3.24.1. Overview

            17.3.24.2. Product Portfolio

            17.3.24.3. Key Financials

            17.3.24.4. SWOT Analysis

            17.3.24.5. Sales Footprint

            17.3.24.6. Strategy Overview

        17.3.25. Pace Analytical Services, LLC

            17.3.25.1. Overview

            17.3.25.2. Product Portfolio

            17.3.25.3. Key Financials

            17.3.25.4. SWOT Analysis

            17.3.25.5. Sales Footprint

            17.3.25.6. Strategy Overview

        17.3.26. Almac Group, Inc.

            17.3.26.1. Overview

            17.3.26.2. Product Portfolio

            17.3.26.3. Key Financials

            17.3.26.4. SWOT Analysis

            17.3.26.5. Sales Footprint

            17.3.26.6. Strategy Overview

        17.3.27. Cambrex Corporation

            17.3.27.1. Overview

            17.3.27.2. Product Portfolio

            17.3.27.3. Key Financials

            17.3.27.4. SWOT Analysis

            17.3.27.5. Sales Footprint

            17.3.27.6. Strategy Overview

        17.3.28. Rottendorf Pharma GmbH

            17.3.28.1. Overview

            17.3.28.2. Product Portfolio

            17.3.28.3. Key Financials

            17.3.28.4. SWOT Analysis

            17.3.28.5. Sales Footprint

            17.3.28.6. Strategy Overview

        17.3.29. Glatt GmbH

            17.3.29.1. Overview

            17.3.29.2. Product Portfolio

            17.3.29.3. Key Financials

            17.3.29.4. SWOT Analysis

            17.3.29.5. Sales Footprint

            17.3.29.6. Strategy Overview

        17.3.30. Hovione

            17.3.30.1. Overview

            17.3.30.2. Product Portfolio

            17.3.30.3. Key Financials

            17.3.30.4. SWOT Analysis

            17.3.30.5. Sales Footprint

            17.3.30.6. Strategy Overview

        17.3.31. Aphena Pharma Solutions

            17.3.31.1. Overview

            17.3.31.2. Product Portfolio

            17.3.31.3. Key Financials

            17.3.31.4. SWOT Analysis

            17.3.31.5. Sales Footprint

            17.3.31.6. Strategy Overview

        17.3.32. HERMES PHARMA GmbH

            17.3.32.1. Overview

            17.3.32.2. Product Portfolio

            17.3.32.3. Key Financials

            17.3.32.4. SWOT Analysis

            17.3.32.5. Sales Footprint

            17.3.32.6. Strategy Overview

18. Assumptions and Acronyms Used

19. Research Methodology

Find Out More about the Report Coverage

List of Tables

Table 01: Global Outsourced Clinical Trials & Formulation Market Size Analysis (US$ Mn) Analysis 2016-2021 and Forecast 2022 – 2027, By Product

Table 02: Global Outsourced Clinical Trials & Formulation Market Size Analysis (US$ Mn) Analysis 2016-2021 and Forecast 2022 – 2027, By Application

Table 03: Global Outsourced Clinical Trials & Formulation Market Size Analysis (US$ Mn) Analysis 2016-2021 and Forecast 2022 – 2027, By End User

Table 04: Global Outsourced Clinical Trials & Formulation Market Size Analysis (US$ Mn) Analysis 2016-2021 and Forecast 2022 – 2027, By Region

Table 05: North America Outsourced Clinical Trials & Formulation Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2027, By Product

Table 06: North America Outsourced Clinical Trials & Formulation Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2027, By Application

Table 07: North America Outsourced Clinical Trials & Formulation Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2027, By End User

Table 08: Europe Outsourced Clinical Trials & Formulation Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2027, By Product

Table 09: Europe Outsourced Clinical Trials & Formulation Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2027, By Application

Table 10: Europe Outsourced Clinical Trials & Formulation Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2027, By End User

Table 11: Asia Pacific Outsourced Clinical Trials & Formulation Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2027, By Product

Table 12: Asia Pacific Outsourced Clinical Trials & Formulation Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2027, By Application

Table 13: Asia Pacific Outsourced Clinical Trials & Formulation Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2027, By End User

Table 14: Rest of the World Outsourced Clinical Trials & Formulation Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2027, By Product

Table 15: Rest of the World Outsourced Clinical Trials & Formulation Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2027, By Application

Table 16: Rest of the World Outsourced Clinical Trials & Formulation Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2027, By End User

Explore Persistence Market Research’s expertise in promulgation of the business !

List of Chart

Figure 01: Global Outsourced Clinical Trials & Formulation Historical Market Size and Y-o-Y, 2016-2021

Figure 02: Global Outsourced Clinical Trials & Formulation Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2027

Figure 03: Global Outsourced Clinical Trials & Formulation Market Absolute $ Opportunity, 2022–2027

Figure 04: Global Outsourced Clinical Trials & Formulation Market Share Analysis (%) By Product, 2022 & 2027

Figure 05: Global Outsourced Clinical Trials & Formulation Market Y-o-Y Growth (%) By Product, 2022-2027

Figure 06: Global Outsourced Clinical Trials & Formulation Market Attractiveness Analysis, By Product

Figure 07: Global Outsourced Clinical Trials & Formulation Market Analysis by Application –2022 & 2027

Figure 08: Global Outsourced Clinical Trials & Formulation Market Y-o-Y Growth Projections by Application, 2022-2027

Figure 09: Global Outsourced Clinical Trials & Formulation Market Attractiveness Analysis, By Application

Figure 10: Global Outsourced Clinical Trials & Formulation Market Share Analysis (%) By End User, 2022 & 2027

Figure 11: Global Outsourced Clinical Trials & Formulation Market Y-o-Y Growth (%) By End User, 2022-2027

Figure 12: Global Outsourced Clinical Trials & Formulation Market Attractiveness Analysis, By End User 

Figure 13: Global Outsourced Clinical Trials & Formulation Market Share Analysis (%) By Region, 2022 & 2027

Figure 14: Global Outsourced Clinical Trials & Formulation Market Y-o-Y Growth (%) By Region, 2022-2027

Figure 15: Global Outsourced Clinical Trials & Formulation Market Attractiveness Analysis, By Region 

Figure 16: North America Outsourced Clinical Trials & Formulation Market Analysis Market Share, By Product (2021)

Figure 17: North America Outsourced Clinical Trials & Formulation Market Analysis Market Share, By Application (2021

Figure 18: North America Outsourced Clinical Trials & Formulation Market Analysis Market Share, By End User (2021)

Figure 19: North America Outsourced Clinical Trials & Formulation Market Analysis Market Share, By Country (2021)

Figure 20: North America Outsourced Clinical Trials & Formulation Historical Market Value (US$ Mn) Analysis, 2016-2021

Figure 21: North America Outsourced Clinical Trials & Formulation Current and Future Market Value (US$ Mn), 2022-2027 & Y-o-Y Growth Trend Analysis

Figure 22: North America Outsourced Clinical Trials & Formulation Market Attractiveness Analysis, By Country

Figure 23: North America Outsourced Clinical Trials & Formulation Market Attractiveness Analysis, By Product

Figure 24: North America Outsourced Clinical Trials & Formulation Market Attractiveness Analysis, By End User

Figure 25: North America Outsourced Clinical Trials & Formulation Market Attractiveness Analysis, By Application

Figure 26: Europe Outsourced Clinical Trials & Formulation Market Analysis Market Share, By Product (2021)

Figure 27: Europe Outsourced Clinical Trials & Formulation Market Analysis Market Share, By Application (2021)

Figure 28: Europe Outsourced Clinical Trials & Formulation Market Analysis Market Share, By Country (2021)

Figure 29: Europe Outsourced Clinical Trials & Formulation Market Analysis Market Share, By End User (2021)

Figure 30: Europe Outsourced Clinical Trials & Formulation Historical Market Value (US$ Mn) Analysis, 2016-2021

Figure 31: Europe Outsourced Clinical Trials & Formulation Current and Future Market Value (US$ Mn), 2022-2027 & Y-o-Y Growth Trend Analysis

Figure 32: Europe Outsourced Clinical Trials & Formulation Market Attractiveness Analysis, By Country

Figure 33: Europe Outsourced Clinical Trials & Formulation Market Attractiveness Analysis, By Product

Figure 34: Europe Outsourced Clinical Trials & Formulation Market Attractiveness Analysis, By Application

Figure 35: Europe Outsourced Clinical Trials & Formulation Market Attractiveness Analysis, By End User

Figure 36: Asia Pacific Outsourced Clinical Trials & Formulation Market Analysis Market Share, By Product (2021)

Figure 37: Asia Pacific Outsourced Clinical Trials & Formulation Market Analysis Market Share, By Application (2021)

Figure 38: Asia Pacific Outsourced Clinical Trials & Formulation Market Analysis Market Share, By Country (2021)

Figure 39: Asia Pacific Outsourced Clinical Trials & Formulation Market Analysis Market Share, By End User (2021)

Figure 40: Asia Pacific Outsourced Clinical Trials & Formulation Historical Market Value (US$ Mn) Analysis, 2016-2021

Figure 41: Asia Pacific Outsourced Clinical Trials & Formulation Current and Future Market Value (US$ Mn), 2022-2027 & Y-o-Y Growth Trend Analysis

Figure 42: Asia Pacific Outsourced Clinical Trials & Formulation Market Attractiveness Analysis, By Country

Figure 43: Asia Pacific Outsourced Clinical Trials & Formulation Market Attractiveness Analysis, By Product

Figure 44: Asia Pacific Outsourced Clinical Trials & Formulation Market Attractiveness Analysis, By Application

Figure 45: Asia Pacific Outsourced Clinical Trials & Formulation Market Attractiveness Analysis, By End User

Figure 46: Rest of the World Outsourced Clinical Trials & Formulation Market Analysis Market Share, By Product (2021)

Figure 47: Rest of the World Outsourced Clinical Trials & Formulation Market Analysis Market Share, By Application (2021)

Figure 48: Rest of the World Outsourced Clinical Trials & Formulation Market Analysis Market Share, By End User (2021)

Figure 49: Rest of the World Outsourced Clinical Trials & Formulation Historical Market Value (US$ Mn) Analysis, 2016-2021

Figure 50: Rest of the World Outsourced Clinical Trials & Formulation Current and Future Market Value (US$ Mn), 2022-2027 & Y-o-Y Growth Trend Analysis

Figure 51: Rest of the World Outsourced Clinical Trials & Formulation Market Attractiveness Analysis, By Application

Figure 52: Rest of the World Outsourced Clinical Trials & Formulation Market Attractiveness Analysis, By End User

Customize this Report

Explore Intelligence Tailored to Your Business Goals.

Recommendations

Methyl Ethyl Ketone Market

The expected value of the global MEK market is expected to be US$ 800.2 Mn in 2018 and the market is estimated to reach US$ 1,055.6 Mn by the end of forecast period..

Polyester Polyols Market

Polyester Polyols Market was valued at US$ 7,788.7 Mn in 2017 and is projected to rise to a valuation of US$ 11,963.6 Mn by the end of 2025..

Polyol Ester Market

As per PMR's research study, global polyol ester market anticipated to rise at a robust CAGR of 5.1% along with a healthy revenue during the forecast period of 2017-2027.

EMEA Dearomatic Solvents Market

Global De-aromatic solvents market is expected to register a CAGR of 5.0% over the forecast period (2016 – 2024), to reach valuation of US$ 556.0 Mn by 2024.

Our Clients

Our Clients